Erratum: Crystallization and preliminary X-ray diffraction analysis of the high molecular weight ketoacyl reductase FabG4 complexed with NADH. Corrigendum

Department of Biotechnology, Indian Institute of Technology, Kharagpur, Kharagpur 721 302, India.
Acta Crystallographica Section F Structural Biology and Crystallization Communications (Impact Factor: 0.53). 07/2012; 68(Pt 7):786-9. DOI: 10.1107/S1744309112020301
Source: PubMed


FabG4 from Mycobacterium tuberculosis belongs to the high molecular weight ketoacyl reductases (HMwFabGs). The enzyme requires NADH for β-ketoacyl reductase activity. The protein was overexpressed, purified to homogeneity and crystallized as a FabG4-NADH complex. A mountable FabG4:NADH complex crystal diffracted to 2.59 Å resolution and belonged to space group P1, with unit-cell parameters a = 63.07, b = 71.03, c = 92.92 Å, α = 105.02, β = 97.06, γ = 93.66°. The Matthews coefficient suggested the presence of four monomers in the unit cell. In addition, a self-rotation function revealed the presence of two twofold NCS axes and one fourfold NCS axis. At χ = 180° the highest peak corresponds to the twofold NCS between two monomers, whereas the second peak corresponds to the twofold NCS between two dimers.

Download full-text


Available from: Debajyoti Dutta
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: FabGs or β-ketoacyl reductases are involved in fatty acid synthesis. The reaction entails NADPH/NADH mediated conversion of β-ketoacyl-ACP to β-hydroxyacyl-ACP. High molecular weight FabGs (HMwFabG) form a phylogenetically separate group of FabG enzymes. FabG4, an HMwFabG of Mycobacterium tuberculosis, comprises of two distinct domains Nterminal "flavodoxin type" domain and C-terminal ketoreductase domain. The catalytically active C-terminal domain utilizes NADH to reduce β-ketoacyl-CoA to β-hydroxyacyl-CoA. Here the crystal structures of FabG4:NADH binary complex and FabG4:NAD+:HexanoylCoA ternary complex have been determined to understand its substrate specificity and catalytic mechanism. This is the first report to demonstrate how FabG4 interacts with its coenzyme NADH and hexanoyl-CoA that mimics an elongating fattyacyl chain covalently linked with coenzyme A. Structural analysis shows that the binding of hexanoyl-CoA within the active site cavity of FabG significantly differs from that of the C16-fattyacyl substrate bound to Mycobacterial FabI (InhA). The ternary complex reveals that both loop-I and loop-II interacts with the phosphopantetheine moiety of CoA or ACP to align the covalently linked fattyacyl substrate near the active site. Structural evidences and ACP inhibition studies indicates that FabG4 can accepts both CoA and ACP based fattyacyl substrates. We have also shown that in FabG4-dimer Arg146 and Arg445 of one monomer interact with the C-terminus of the second monomer to play pivotal role in substrate association and catalysis.
    Full-text · Article · Nov 2012 · Biochemical Journal
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report the design and synthesis of triazole-polyphenol hybrid compounds and as inhibitors of the FabG4 (Rv0242c) enzyme of Mycobacterium tuberculosis for the first time. A major advance in this field occurred only a couple of years ago with the X-ray crystal structure of FabG4, which has helped us to design these inhibitors by the computational fragment-based drug design (FBDD) approach. Compound has shown competitive inhibition with an inhibition constant (Ki) value of 3.97 ± 0.02 μM. On the other hand, compound has been found to be a mixed type inhibitor with a Ki value of 0.88 ± 0.01 μM. Thermodynamic analysis using isothermal titration calorimetry (ITC) reveals that both inhibitors bind at the NADH co-factor binding domain. Their MIC values, as determined by resazurin assay against M. smegmatis, indicated their good anti-mycobacterial properties. A preliminary structure-activity relationship (SAR) study supports the design of these inhibitors. These compounds may be possible candidates as lead compounds for alternate anti-tubercular drugs. All of the reductase enzymes of the Mycobacterium family have a similar ketoacyl reductase (KAR) domain. Hence, this work may be extrapolated to find structure-based inhibitors of other reductase enzymes.
    Full-text · Article · Oct 2013 · Organic & Biomolecular Chemistry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Herein we report six novel triazole linked polyphenol-aminobenzene hybrids (3-8) as inhibitors of Mycobacterium tuberculosis FabG4 (Rv0242c), a less explored β-ketoacyl CoA reductase that has immense potential to be the future anti-tuberculosis drug target due to its possible involvement in drug resistance and latent infection. Novel triazole linked polyphenol-aminobenzene hybrids have been synthesized, characterized and evaluated for their inhibitory activity against FabG4. All of them inhibit FabG4 at low micromolar concentrations. In silico docking study has been carried out to explain the experimental findings. A comparative study of these new inhibitors with previously reported gallate counterparts leads to structure-activity relations (SAR) of substituent linked to N-1 of triazole ring. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Full-text · Article · Jan 2015 · Bioorganic & Medicinal Chemistry Letters